about
Orchestrating differential data access for translational research: a pilot implementation.Future opportunities and trends for e-infrastructures and life sciences: going beyond the grid to enable life science data analysisModel structures of alpha-2 adrenoceptors in complex with automatically docked antagonist ligands raise the possibility of interactions dissimilar from agonist ligands.Structural basis for computational screening of non-steroidal androgen receptor ligands.Molecular mechanisms of ligand-receptor interactions in transmembrane domain V of the alpha2A-adrenoceptor.Best practices in bioinformatics training for life scientistsBioinformatics training: a review of challenges, actions and support requirements.Bioinformatics Training Network (BTN): a community resource for bioinformatics trainers.Computational and functional analysis of the androgen receptor antagonist atraric acid and its derivatives.SOMA--workflow for small molecule property calculations on a multiplatform computing grid.Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine.Determinants of antagonist binding at the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit, GluR-D. Role of the conserved arginine 507 and glutamate 727 residues.BRUTUS: optimization of a grid-based similarity function for rigid-body molecular superposition. 1. Alignment and virtual screening applications.A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods.Comparing the quality and predictiveness between 3D QSAR models obtained from manual and automated alignment.An in silico approach to discovering novel inhibitors of human sirtuin type 2.Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain.Molecular evolution of adrenoceptors and dopamine receptors: implications for the binding of catecholamines.Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function.BODIL: a molecular modeling environment for structure-function analysis and drug design.Registered access: authorizing data accessGlucuronidation Converts Clopidogrel to a Strong Time-Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug–Drug InteractionsCommon ELIXIR Service for Researcher Authentication and Authorisation“RKKH” Peptides from the Snake Venom Metalloproteinase ofBothrops jararacaBind Near the Metal Ion-dependent Adhesion Site of the Human Integrin α2I-domainDelivering ICT infrastructure for biomedical researchSOMA2 – open source framework for molecular modelling workflowsThree-dimensional Models of α2A-Adrenergic Receptor Complexes Provide a Structural Explanation for Ligand BindingA linear open-chain piperazine-pyridine ligand and its meso-helical Co complexAn MO study of neutral C8 high-symmetry clustersDocking and three-dimensional quantitative structure-activity relationship (3D QSAR) analyses of nonsteroidal progesterone receptor ligands
P50
Q30491200-4E5E0BF0-C780-4AE3-BCE1-6AB94469CE44Q30979394-25F9E0A9-9CDA-4211-89C4-AEBD7DB1C401Q31167652-4B4C9196-C132-464E-B97D-2ECFAC824923Q34289773-7A806A44-D6AB-4B56-8360-CE133040D8AEQ35045705-72DF0E11-0C47-4DB2-B8C1-D99AC5C43AEFQ37165986-D3C3845A-AB2F-47E6-8BB0-0606130C8E1AQ37766386-9C61AFD8-AFE3-4161-B73C-DBFFF0CB739FQ37959938-623CFCD9-A76A-41FB-8A88-79BDD3F4F6F0Q38063590-9720A6DF-137F-4D92-B195-F7E7194BE703Q38444600-623D25D2-2B3F-4D04-B3EA-700611EBBD30Q39949306-521C28BE-9650-4F0C-AB25-8E412FEBE6FDQ43578327-D5FF286A-7F6B-4A4A-8685-E8D595B64B63Q44243048-59196935-4DB8-402E-9A25-3EAB836C9DF4Q44547496-58C054C0-BA93-41A8-9FB2-ED73E4D42A6CQ44882009-6556C3EB-01C2-49CF-9AB3-313DF3CDB1FBQ44904068-A9AE9BD7-0B79-41BC-A17E-C8EA71C7A5E6Q45164332-0611C5FB-DDE2-4751-B1FE-77B5EE7057B2Q45268949-751BA850-D0C1-4D35-867C-BF2B00D393C8Q46970004-CFDD7062-6C5B-4F85-80D5-E35787F46E98Q51798054-8261722C-557E-4A5E-A487-3A49DE5CF89EQ51979864-076336F5-8DB1-4E4E-9E82-0926EE63BDB9Q56395225-D5187D75-C944-4631-AB14-E7D295BFEF41Q57825105-6682D5B6-497E-46A4-A7F4-61BF6035F944Q58798462-5984A6BD-FD39-4C38-BE96-F5D10157A799Q60340673-682615AD-6A66-4A3F-924A-29EDCA024EE9Q60395865-A9839FE8-CC5D-4AC0-8053-A9119C9FB71BQ60788081-C565BD6A-1BC4-4EA7-AC91-21DCEEE21B9BQ60788085-0B067567-D935-4F15-B262-9C28BE575295Q60788087-63740030-E91C-45B1-8A5F-8C213B7FD72FQ60788089-FC7675B2-9083-4A5F-B0BB-8BDF4895D5DCQ79842094-6550640B-8101-4B1E-970C-57F9B2E87F93
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tommi Nyrönen
@ast
Tommi Nyrönen
@de
Tommi Nyrönen
@en
Tommi Nyrönen
@es
Tommi Nyrönen
@nl
type
label
Tommi Nyrönen
@ast
Tommi Nyrönen
@de
Tommi Nyrönen
@en
Tommi Nyrönen
@es
Tommi Nyrönen
@nl
prefLabel
Tommi Nyrönen
@ast
Tommi Nyrönen
@de
Tommi Nyrönen
@en
Tommi Nyrönen
@es
Tommi Nyrönen
@nl
P106
P1153
6602986464
P21
P2456
P31
P496
0000-0002-5569-5183